References
1. Kass M, Arya VK, Shah AH. COVID-19-Positive Patient and Hypoxemia:
Are Lungs Always to Be Blamed? JACC Cardiovasc Interv.
2021;14:e101-e102.
2. Vanhomwegen C, Taton O, Selvais N, et al. Patent foramen ovale
revealed by COVID-19 pneumonia. BMC Pulmonary Medicine. 2021;21:126.
3. Rigatelli G, Zuin M. Managing patent foramen ovale in COVID-19
patients during and after viral infection: an unresolved matter. J
Cardiovasc Med (Hagerstown). 2021;22:259-260.
4. Rajendram R, Kharal GA, Mahmood N, et al. Systemic thromboemboli in
patients with Covid-19 may result from paradoxical embolization. Thromb
Res. 2020;196:206-208.
5. Fisher HK. Hypoxemia in COVID-19 patients: An hypothesis. Med
Hypotheses. 2020;143:110022.
6. Trifi A, Ouhibi A, Mahdi A, et al. Shunt in critically ill Covid-19
ARDS patients: Prevalence and impact on outcome (cross-sectional study).
Journal of Critical Care. 2022;70:154048.
7. Shah R, Nayyar M, Jovin IS, et al. Device Closure Versus Medical
Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic
Stroke: A Systematic Review and Meta-analysis. Ann Intern Med.
2018;168:335-342.
8. Musuku SR, Srikanthan A, Cherukupalli D, et al. NobleStitch EL PFO
Closure Guided by Transesophageal Echocardiography. J Cardiothorac Vasc
Anesth. 2020.
9. Gaspardone A, De Marco F, Sgueglia GA, et al. Novel percutaneous
suture-mediated patent foramen ovale closure technique: early results of
the NobleStitch EL Italian Registry. EuroIntervention.
2018;14:e272-e279.
10. Gaspardone A, Sgueglia GA, De Santis A, et al. Predictors of
Residual Right-to-Left Shunt After Percutaneous Suture-Mediated Patent
Fossa Ovalis Closure. JACC Cardiovasc Interv. 2020;13:2112-2120.
11. Zannoni J, Popolo Rubbio A, Tusa MB, et al. Mechanisms of
ineffective patent foramen ovale closure using the percutaneous
suture-mediated NobleStitch system. EuroIntervention. 2022.
12. Prospective Multi Center Comparative Parallel Concurrent Study of
the NobleStitch EL Compared to FDA Approved Amplatzer Occluder Device
for Closure of Patent Foramen Ovale to Prevent Recurrent Ischemic
Stroke; Available at:
https://clinicaltrials.gov/ct2/show/NCT04339699?term=noblestitch&draw=2&rank=1.
Accessed March, 2022.
13. Ashraf M, Sajed S. Acute Stroke in a Young Patient With Coronavirus
Disease 2019 in the Presence of Patent Foramen Ovale. Cureus.
2020;12:e10233.
14. Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in
patients with COVID-19: A systematic review and meta-analysis. Res Pract
Thromb Haemost. 2020;4:1178-1191.
15. Scoccia A, Laricchia A, Ielasi A, et al. TCT-479 Percutaneous
Suture-Based Closure of Patent Foramen Ovale: Initial Results of a
Multicenter Experience in a Highly Selected Population. J Am Coll
Cardiol. 2021;78:B197-B197.